Session Information
Date: Wednesday, September 25, 2019
Session Title: Non-Motor Symptoms
Session Time: 1:15pm-2:45pm
Location: Agora 3 West, Level 3
Objective: To compare the performance of the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and its predecessor, the Non-Motor Symptoms Scale (NMSS).
Background: The NMSS was the first comprehensive assessment for non-motor symptoms (NMS) in Parkinson disease (PD). The MDS-NMS has been recently developed based on the original NMSS, literature review, and expert consensus, to expand and refine the assessment of NMS.
Method: Multi-center, cross-sectional study to validate MDS-NMS in a sample of 402 PD patients recruited from movement disorders clinics in UK and US. Data on socio-demographic characteristics and PD treatment were obtained. The MDS-NMS was administered together along with the NMSS. Frequency of NMS (i.e., scores >0) by items and domains, mean and standard deviation (SD), comparison of scores in the sample grouped by age, sex, PD duration, Hoehn and Yahr stage (HY), and levodopa-equivalent daily dose (LEDD) were calculated.
Results: The sample (62.2% men) had mean age of 67.42 years old (SD: 9.96), PD duration of 8.2 years (SD: 5.93), and mainly HY stage 2 (54.5%). Mean total scores were: MDS-NMS, 79.33 (SD: 65.87, range: 0-334) and NMSS, 41.39 (SD: 35.2, range: 0-197). Most prevalent MDS-NMS domains were K. Sleep & Wakefulness (86.5%) and F. Cognition and M. Other (both, 80.1%). For NMSS, most prevalent domains were 2. Sleep/fatigue (79.9%) and 7. Urinary (73.3%). MDS-NMS items L1. Muscle/joint/back pain (67.5%) and F1. Difficulty remembering things (59.2%), and NMSS items 28. Change in ability to taste/smell (54.7%) and 17. Forgetting things (52.5%) were the most prevalent individual symptoms. Neither MDS-NMS nor NMSS total scores showed significant differences by sex or age groups, but both increased with increasing PD duration and LEDD (p<0.001). Most MDS-NMS and NMSS domains scores also increased with increasing HY stages (p<0.01).
Conclusion: Due to the inherent similarities, there are overlapping attributes of the MDS-NMS and NMSS (e.g., score distribution by groups), but differences are also evident (e.g., in frequency of individual NMS) because of their structural dissimilarities.
To cite this abstract in AMA style:
A. Schrag, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, KR. Chaudhuri, P. Martinez-Martin. Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS) [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/comparison-between-the-movement-disorders-society-non-motor-rating-scale-mds-nms-and-the-non-motor-symptoms-scale-nmss/. Accessed November 24, 2024.« Back to 2019 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/comparison-between-the-movement-disorders-society-non-motor-rating-scale-mds-nms-and-the-non-motor-symptoms-scale-nmss/